Ballew Advisors’s Celgene Corp CELG Stock Holding History

Ballew Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-200	Closed	-$14K	–	519
2018 Q3	$14K	Hold	200	–	–	0.01%	270
2018 Q2	$16K	Buy	+200	New	+$16.6K	0.02%	262

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ballew Advisors's CELG Position: Q4 2018 in Review

Ballew Advisors sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 200 shares — an estimated $14K sold.

Ballew Advisors first reported a position in CELG in Q2 2018 and held it in 2 quarters. The position peaked at $16K in Q2 2018. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

Ballew Advisors reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
Ballew Advisors sold 200 Celgene Corp shares in Q4 2018, an estimated $14K.
Ballew Advisors first reported a position in Celgene Corp in Q2 2018 and held it in 2 quarters.
Ballew Advisors's Celgene Corp position peaked at $16K in Q2 2018.
1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Ballew Advisors's 13F filing for Q4 2018, filed 12 Feb 2019.